MedPath

A clinical trial to study the outcomes of two intraoperative fluid management strategies to guide fluid therapy in renal transplant recepient patients

Not yet recruiting
Conditions
End stage renal disease,
Registration Number
CTRI/2018/01/011638
Lead Sponsor
Postgraduate institute of medical education and researchPGIMER Chandigarh
Brief Summary

This study is a randomized double blind controlled study to determine determine the ability of Pulse PressureVariation guided fluid therapy as an alternative to CVP guided fluid therapy inrenal transplant recipients by assessing the amount of fluid used in both groups and tissue perfusion by lactate levels in both the groups and urine output and dialysis requirement in both the groups

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria

Patients with End Stage Renal Disease undergoing Renal Transplantation.

Exclusion Criteria

Active coronary artery disease or congestive heart failure Atrial fibrillation or flutter Valvular Heart Disease Significant pulmonary insufficiency.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the ability of Pulse Pressure Variation guided fluid therapy as an alternative to CVP guided fluid therapy in renal transplant recipients by comparing the amount of fluid administered at the end of surgery1 hour post op
Secondary Outcome Measures
NameTimeMethod
To compare adequacy of tissue perfusion at the end of surgery.To find out the total volume of fluid administered in two groups during surgery and in theimmediate post-operative period

Trial Locations

Locations (1)

Postgraduate institute of medical education and research, Chandigarh

🇮🇳

Chandigarh, CHANDIGARH, India

Postgraduate institute of medical education and research, Chandigarh
🇮🇳Chandigarh, CHANDIGARH, India
Dr Gowtham K
Principal investigator
8113857581
kgdx08@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.